Progressive
Care Inc. Announces $3.7
Million Gross Revenue for August 2019
MIAMI,
FL -- September 24, 2019 -- InvestorsHub NewsWire
-- Progressive
Care Inc. (OTCQB:
RXMD),
a personalized healthcare services and technology company, today
announced further growth year-over-year in revenue and number of
prescriptions filled for August
2019.
August
2019
sales continued to increase with
$3.7 Million in gross revenue and approximately 47,000
prescriptions filled between the 4 locations in Florida. Gross
revenue does not include PBM clawbacks for DIR or other fees.
Revenues increased by 94% over the same month last year and
prescriptions filled increased 62%. These increases are
attributable to the acquisition of FPRX in June 2019 as well as
organic growth in same store operations.
"The Company continues to
excel in the pharmacy industry," said S. Parikh Mars, Chief
Executive Officer of Progressive Care
Inc. "Although we are proud of our overall achievements this year,
there is still urgency to do better and realize the true potential
of this enterprise. We are focused on delivering innovative
solutions to healthcare market and look to capitalize on strategic
and transformative relationships."
For
more information about Progressive Care, please visit the
company's website.
Connect and stay
in touch with us on social media:
Progressive
Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About
Progressive Care Inc.
Progressive Care
Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a
South Florida health services organization and provider of
prescription pharmaceuticals, compounded medications, provider of
tele-pharmacy services, the sale of anti-retroviral medications,
medication therapy management (MTM), the supply of prescription
medications to long-term care facilities, and health practice risk
management.
Cautionary Statement Regarding Forward-Looking Statements
Statements
contained herein that are not based upon current or historical fact
are forward-looking in nature and constitute forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Such forward-looking statements reflect the Company's expectations
about its future operating results, performance, and opportunities
that involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
"anticipate," "believe," "estimate," "upcoming," "plan," "target,"
"intend" and "expect" and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Investor
Relations Contact:
Armen Karapetyan,
Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public
Relations Contact:
Kathleen
Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Web and
Application Development Contact:
Marcello Jaspan,
Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com